A recent study has raised concerns over the potential cardiac risks associated with long-term melatonin usage, suggesting an 89% increase in heart failure risk among users prescribed melatonin for over a year.
Melatonin is among the most commonly used supplements for treating insomnia. However, a recent analysis has alarmed some specialists as it detected a potential relationship between prolonged use of melatonin and cardiac problems. This study, conducted by researchers at SUNY Downstate Health Sciences University in Brooklyn, New York, analyzed data from over 130,000 adults suffering from insomnia across various countries. The findings indicated that individuals who were prescribed melatonin for more than a year showed an 89% higher risk of heart failure within a five-year period compared to those not receiving the supplement.
In addition to the increased risk of heart failure, the analysis revealed that those who used melatonin long-term had double the likelihood of dying from any cause compared to those who did not take the supplement. According to further reports, these patients had nearly three and a half times more chances of facing serious health complications. The implications of these findings may prompt healthcare providers to reassess the criteria for prescribing melatonin, especially for extended periods, urging a more cautious approach in its use for insomnia treatment.
As melatonin is freely available and widely used, this study underscores the importance of ongoing research into the long-term health effects of supplements that are commonly perceived as benign. Given the scale of usage and the serious nature of the potential risks uncovered, there may be a significant shift in how melatonin is perceived within the treatment landscape for sleep disorders, highlighting a need for greater education and awareness among both healthcare professionals and patients.
